참고문헌
- Central Cancer Registry Center Ministry of Health and Welfare, Korea. Annual report of the central cancer registry in Korea 2002
- Shankar A, Russell RC. Recent advances in the surgical treatment of pancreatic cancer. World J Gastroenterol 2001; 7:622-626 https://doi.org/10.3748/wjg.v7.i5.622
- Lee SJ. Clinical study on pancreatic cancer and its prognostic factors. Korean J Gastoenterol 1994;26: 1010-1020
- Whang YW, Chang HJ, Lee JK, et al. Survival and recurrence pattern after curative resection of pancreatic cancer. Korean J Gastoenterol 2001 ;38:276-283
- Ghaneh P, Slavin J, Sutton R, et al. Adjuvant therapy in pancreatic cancer. World J Gastroenterol 2001;7:482-489 https://doi.org/10.3748/wjg.v7.i4.482
- Shinchi H, Takao S, Noma H, et al. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2002;53: 146-150 https://doi.org/10.1016/S0360-3016(01)02806-1
- Fisher BJ, Perera FE, Kocha W, et al. Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 1999;45:291-295
- Kornek GV, Potter R, Selzer E, et al. Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine. Int J Radiat Oncol Biol Phys 2001; 49:291-295 https://doi.org/10.1016/S0360-3016(00)00773-2
- Andre T, Balosso J, Louvet C, et al. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. Int J Radiat Oncol Biol Phys 2000;46: 903-911 https://doi.org/10.1016/S0360-3016(99)00478-2
- Ben-Josef E, Shields AF, Vaishampayan U, et al. Intensity-modulated radiotherapy (1MRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;59:454-459 https://doi.org/10.1016/j.ijrobp.2003.11.019
- Nishimura Y, Hosotani R, Shibamoto Y, et al. External and intraoperative radiotherapy for respectable and unresectable pancreatic cancer: analysis of survival rates and complications. Int J Radiat Oncol Biol Phys 1997;39:39-49 https://doi.org/10.1016/S0360-3016(97)00295-2
- Koong AC, Le QT, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;58:1017-1021 https://doi.org/10.1016/j.ijrobp.2003.11.004
- Kim JG, Lee DH, Kim MS, et al. A study of the reduction of organ motion from respiration. Korea J Medi Phy 2004;15:179-186
- Mortel GG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6,000 rads) radiation alone, moderate dose radiation (4,000 rads+5-fluorourcil), and high dose radiation + 5-fluorouracil. The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705-1710 https://doi.org/10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4
- Klaassen DJ, Maclntyre JM, Catton GE, et al. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil: an Eastern Cooperative Oncology Group Study. J Clin Oncol 1985;3:373-378 https://doi.org/10.1200/JCO.1985.3.3.373
- Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined modality therapy(chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988;80:751-755 https://doi.org/10.1093/jnci/80.10.751
- Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-Fluorouracil for locally unresectable pancreatic carcinoma. Ann Surgery 1979;189-205
- Whittington R, Neuberg D, Tester WJ, et al. Protracted intravenous flourouracil infusion with radiotherapy in the management of localized pancreaticobiliary carcinoma: 1 phase Eastern Cooperative Oncology Group trial. J Clin Oncol 1995;13:227-232 https://doi.org/10.1200/JCO.1995.13.1.227
- Treurniet-Donker AD, Van Mielro MJM, Van Putten WLJ, et al. Localized unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 1990;18:560-562
- Ishii H, Okada S, Tokuuye. et al. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer 1997;79:1516-1520 https://doi.org/10.1002/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0
- Okusaka T, Okada S, Tokuuye K, et al. Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma. Cancer 2001;91:1384-1389 https://doi.org/10.1002/1097-0142(20010401)91:7<1384::AID-CNCR1142>3.0.CO;2-4
- Safran H, Moore T, lannitti D, et al. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2001;49:1275-1279 https://doi.org/10.1016/S0360-3016(00)01527-3
- Crane CH, Janjan NA, Evans DB, et al. Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol 2001;29:9-18 https://doi.org/10.1385/IJGC:29:1:09
- Li CP, Chao Y, Chi KH, et al. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. Int J Radiat Oncol Biol Phys 2003;54:137-141
- Kim YB, Seong JS, Song SY, et al. Concurrent chemoradiotherapy for unresectable pancreatic cancer. J Korean Soc Ther Radiol Oncol 2002;20:328-333
- Wanebo HJ, Glicksman AS, Vezeridis MP, et al. Preoperative chemotherapy, radiotherapy and surgical resection of locally advanced pancreatic cancer. Arch Surg 2000;35:81-87
- Kamthan AG, Morris JC, Dalton J, et al. Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 1997;15:2920-2927 https://doi.org/10.1200/JCO.1997.15.8.2920
- Martin JL. Harvey HA. Lipton A, et al. Combined chemoradiotherapy for unresectable pancreatic cancer. Am J Clin Oncol 1999;22:309-314 https://doi.org/10.1097/00000421-199906000-00021
- Morganti AG, Valentini V, Macchia G, et al. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: phase I-II dose-escalation study. Int J Radiat Oncol Biol Phys 2004;59: 1454-1460 https://doi.org/10.1016/j.ijrobp.2004.01.035
- Talamonti MS, Catalano PJ. Vaughn DJ, et al. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity. J Clin Oncol 2000;135:81-87
- Bai YR. Wu GH, Guo WJ, et al. Intensity modulated radiation therapy and chemotherapy for locally adcanced pancreatic cancer: results of feasibility study. World J Gastreenterol 2003;9:2561-2564 https://doi.org/10.3748/wjg.v9.i11.2561
- Song DY. Blomgren H. Stereotactic body radiation therapy for lung tumors. In: Kavanagh BD, Timmerman RD, eds. Stereotactic body radiation therapy. 1st ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2005:99-107
- Schetter TE, Cardenes HR, Kavanagh BD. Stereotactic body radiation therapy for liver tumors. In: Kavanagh BD, Timmerman RD, eds. Stereotactic body radiation therapy. 1st ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2005;115-124
- Fowler JF, Tome WA, Welsh JS. Estimation of required doses in stereotactic body radiation therapy. In: Kavanagh BD, Timmerman RD, eds. Stereotactic Body Radiation Therapy. 1st ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2005:7-14